Sintilimab for Relapsed/refractory Extranodal NK/T Cell Lymphoma: a Multicenter, Single-Arm, Phase 2 Trial (ORIENT-4)
Signal Transduction and Targeted Therapy（2021）
Key words
Mantle Cell Lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined